-
8:00 AM
REGISTRATION & LIGHT BREAKFAST
-
9:00 AM
Chairperson Opening Remarks
-
09:10 AM
Panel: From Pilot Purgatory to Production: The AI Infrastructure Turning Point in Healthcare & Pharma
- Why most 2023–2024 pilots stalled at scale, and what separated the organisations that broke through
- The “clean sheet” mindset: asking whether a process should exist at all before applying AI
- Treating AI fluency as foundational infrastructure rather than a bolt-on capability
- What a credible, board-ready scaling roadmap looks like over the next 12–18 months
Moderator: Erlyn Macarayan, PhD, Vice President of Data Science – PatientsLikeMe (Fuze Health)
Fariha Chaudry, Head of Engineering M&A - GE HealthCare
Brian Schick, Director, Digital Product Strategy & Development Lead – Takeda
Priyam Raut, Principal Engineer -Eli Lilly and Company
Yunpeng Liu-Lupo, PhD, Senior Director, Analytical AI Clinical Development – Bristol Myers Squibb
-
09:40 AM
Presentation: Deployed Is Not Adopted: What Healthcare and Pharma Must Do to Realize AI Value
Jon Brockway - Vice President, Solution Advisory – Americas - WalkMe Inc.
- Why digital transformation in healthcare and pharma so often falls short, and why AI raises the stakes
- How AI tools are widely deployed yet often underused
- Turnover, burnout, and constant change: the workforce realities that slow rollout
- A practical operating model for AI adoption and value realization
-
10:10 AM
Spotlight session: From a custom AI research assistant to Databricks Genie: lessons from Pfizer's R&D journey.
Jay Bergeron - Senior Director - Pfizer
- Why few AI tools are widely used by clinicians and staff after deployment
- Bringing AI guidance into the applications where work happens
- Creating comfort and confidence in AI tools so their benefits can be realized
- Showing leaders where adoption stalls, by role and by site
-
10:30 AM
Coffee and Networking Break in the Exhibit Area
-
Track A: Pharma
-
11:10 AM
Accelerating TrialOps: Evolving Process and Empowering People with the Right Tech
Yunpeng Liu-Lupo, PhD, - PhD, Senior Director, Analytical AI Clinical Development - Bristol Myers Squibb
- Why plans firm up too late: country, site and enrollment decisions are usually settled after cost and value are already locked in.
- Testing eligibility before it's written in: an automated patient funnel shows what each criterion costs in reachable patients.
- From protocol to sites and enrollment: dose-escalation simulation for Phase 1, plus site ranking and bottom-up enrollment forecasts for late-phase studies.
- A plan ready at protocol final: enrollment drives resourcing and start-up, so by protocol final the operational decisions are already worked through.
-
11:40 AM
Case study: From Copilots to an Agentic Enterprise: Building Reusable AI Capabilities at Scale
Manohar Boorlu - Associate Director, AI Lead - Novartis
-
Track B: Healthcare
-
11:10 AM
Discussion group: Frameworks for Evaluating LLMs in Clinical Settings
- A practical, validation-first approach to selecting clinical AI tools
- Embedding LLM-powered tools directly and safely into EHR workflows
- Guardrails for hallucination, accuracy, and specialty coverage
- Evidencing real-world clinical performance, not benchmark scores
Anemone Kasasbeh,PhD, Manager of Data Science and Clinical AI – Ascension
Amir Tahmasebi, Head of AI Algorithms and Infrastructure – BD
-
11:40 AM
Case study: Predictive AI for Proactive Population Health
Anemone Kasasbeh, PhD - Manager of Data Science and Clinical AI - Ascension
- Shifting from reactive treatment to anticipatory, data-driven care
- Identifying at-risk populations earlier across diverse communities
- Designing for equity so models serve underserved groups fairly
- Connecting predictive insight to action across provider and payer workflows
-
12:30 PM
Lunch & Networking in the Exhibition Area
-
12:30-13:30
Invite-only Lunch Roundatble Roundtable: How Leaders Can Prove Their AI ROI, from Pilot to Production
Jon Brockway - Vice President, Solution Advisory – Americas - WalkMe Inc.
- Defining ROI measures for AI adoption: usage, proficiency, errors, and staff time returned
- Linking adoption data to outcomes such as claim accuracy, support volume, and workforce productivity
- How to differentiate tool performance challenges from workforce adoption challenges
- Sharing what works across sites, roles, and high-turnover teams
-
1:30 PM
Presentation: Modernize Patient Access While Keeping Human Judgement
Mike Hayes - AVP, Enterprise Sales - Dialpad
- Identify patient-access workflows suited to AI and define where human judgment must remain
- Learn how to test exceptions, assign ownership, and build a focused, accountable pilot
- Measure success through patient access, effort, and handoff quality
- Learn how real organizations are approaching conversational intake, contextual handoffs, and workflow improvement
-
2:00 PM
Fireside chat: Beyond the Visit: Can Wearables and AI Transform Clinical Trials?
- Turning continuous patient data into meaningful clinical evidence.
- Where AI can uncover signals that scheduled trial visits miss.
- Tackling data quality, patient adherence and digital endpoint validation.
- What it takes to move wearable-enabled trials from promise to practice.
Tim Pagliaro, Co-Founder -Orchid Research Platform
Elias Abou Zeid, PhD, Principal Data Scientist, AI & Analytics – Novo Nordisk
-
2:30 PM
Panel: Governance in Practice — What a Real Enterprise Playbook Looks Like
-
- Moving governance from a compliance checkbox to a genuine strategic enabler
- Cutting through the noise: separating real capability from vendor hype
- Explainability, bias auditing, and audit trails built into the model lifecycle
- Aligning internal playbooks with evolving FDA, EMA, and EU AI Act expectations
Moderator: Swathi Varahabhatla, Healthcare Business and Data Analytics Lead, Provider directory accuracy - Blue Cross Blue Shield of Massachusetts
Manasi Ghogare, Senior Technical Product Manager, Digital Health – Takeda
Marissa Seligman, PharmD, VP, Clinical Data Optimization, Real-World Data Solutions - Optum Life Sciences
Dr. h.c. Frederik Wenz is Chief Medical Officer, CEO of the Medical Center – University of Freiburg
Nirav Parikh, Head of Enterprise Data and AI - Mass General Brigham Healthcare
-
-
3:00 PM
Afternoon Networking Break
-
3:30 PM
Panel: Operationalising AI Across the Pharma Enterprise
- Breaking silos and building cross-functional alignment at scale
- Embedding governance without slowing scientific progress
- Moving from efficiency gains to genuinely new decision-making capability
- Translating enterprise AI investment into measurable patient outcomes
Moderator: Marktus Atanga, Senior Data Scientist– Moderna
Adem Albayrak, Chief Data & AI Officer - Alzheon
Lily Xu, PhD, Director, Clinical Data Science – Vertex Pharmaceuticals
Brian Schick, Director, Digital Product Strategy & Development Lead – Takeda
Mark Aquino, Director of Scientific Applications -AbbVie
-
4:15 PM
Panel: Proving ROI — Aligning Clinical Value, Cost & Executive Buy-In
- Quantifying and communicating AI’s return to the C-suite and board
- Building scalable infrastructure that meets regulatory expectations
- Navigating budget constraints and cross-functional resistance
- Defining the metrics that signal an AI programme is genuinely working
Moderator: Dr. h.c. Frederik Wenz is Chief Medical Officer, CEO of the Medical Center – University of Freiburg
Parisa Farzam, Blavatnik Fellow in Healthcare and Life Sciences - Harvard Business School
Vanessa Kitova, Staff Data Scientist - AI/ML, Enterprise AI -GE HealthCare
-
5:00 PM
Closing Remarks
-
5:00 PM
Networking Drinks Reception in the Exhibition Area
-
6:00 PM
End of Day 1
Not Found
-
8:00 AM
REGISTRATION & LIGHT BREAKFAST
-
MORNING SESSIONS
-
9:00 AM
Chairperson Opening Remarks
Anemone Kasasbeh,PhD, - Manager of Data Science and Clinical AI - Ascension
-
9:10 AM
OPENING KEYNOTE: Building the Foundations for Agentic AI in Healthcare: Data, Context and Governance
Nirav Parikh - Head of Enterprise Data and AI - Mass General Brigham Healthcare
-
9:40 AM
Spotlight session by WalkMe: See Healthcare AI Go From Ignored to Indispensable in 10 Minutes
Jon Brockway - Vice President, Solution Advisory – Americas - WalkMe Inc.
- See errors caught at the point of entry, before they become a financial loss or risk
- Learn how a new hire can complete a complex task correctly on the first try
- Discover AI guidance that prompts the user inside a live application, at the moment of need
- Understand the analytics leaders use to spot where AI adoption stalls.
-
10:00 AM
Presentation: Why AI Demos Don’t Deliver Healthcare Innovation
Rafael Areses, - Medical Doctor MD DDS OS, Senior Advisor, Author and AI Tech Speaker -
- Beyond the demo: what separates technical success from measurable patient value?
- Scale, improve or stop: designing AI pilots around clear decisions, budgets and accountability.
- Who pays, who leads, who owns the risk? Tackling the unanswered questions that stall adoption.
- Making AI work in clinical practice: aligning safety, sustainable funding and everyday workflows.
-
10:30 AM
Coffee and Networking Break in the Exhibition Area
-
11:00 AM
Panel: Beyond the Chatbot: Scaling Conversational AI Across the Patient Journey
- Integrating patient-reported outcomes, wearable data and remote monitoring into clinical workflows to build a more complete picture of patients between visits.
- Using conversational AI, voice and SMS to collect patient updates, identify emerging concerns and support more personalised follow-ups.
- Turning continuous patient data into actionable insights, with clear escalation pathways that help care teams distinguish meaningful clinical signals from noise.
- Measuring whether AI-enabled patient engagement improves care navigation, early intervention and patient outcomes without increasing clinicians’ workload.
Moderator: Joy H. Lewis, DO, PhD,Professor of Internal Medicine and Public Health; Founder, National Center for Community Health Research; Medical Advisor, Allimb -A .T. Still University
Erlyn Macarayan, PhD, Vice President of Data Science - PatientsLikeMe (Fuze Health)
Manasi Ghogare, Senior Technical Product Manager, Digital Health – Takeda
-
11:30am
Fireside chat: From Scientific Promise to Commercial Product — Scaling AI Across the Product Lifecycle
• Translating experimental AI capability into a validated, supported business offering
• Aligning medical, regulatory, market access, commercial, and technology teams
• Building a credible value proposition for providers, payers, researchers, and patients
• Avoiding the transition gap between successful prototype and sustainable product
Moderator: Joy H. Lewis, DO, PhD,Professor of Internal Medicine and Public Health; Founder, National Center for Community Health Research; Medical Advisor, Allimb -A .T. Still University
Cheng Yang, Digital Diagnostics Lead - Tekeda
-
12:00 AM
PANEL: Partner, Build or Buy? Who Owns the AI and the Risk?
- Deciding where to build proprietary AI capabilities, buy external solutions or partner for greater impact.
- Evaluating technology providers, startups and research partners beyond technical promises and vendor hype.
- Defining ownership, accountability and liability when AI systems influence critical decisions.
- Structuring partnerships that protect intellectual property, enable data sharing and distribute risk while delivering measurable outcomes.
Moderator: Rafael Areses, Medical Doctor MD DDS OS, Senior Advisor, Author and AI Tech Speaker
Dalbir Bains, President & CEO - Galaxy Pharmaceuticals LLC
Amir Tahmasebi, Head of AI Algorithms and Infrastructure – BD
Jacey Zhang, Associate Director - AI & Digital Enablement Lead -Takeda
-
12:30 PM
Lunch and Networking in the Exhibit Hall
-
1:30 PM
Fireside chat: Trust at Scale — What Patients, Professionals & Regulators Need to See
• Moving beyond broad principles to visible evidence of safety, fairness, and accountability
• Communicating how AI is used without overwhelming patients or frontline professionals
• Responding transparently when models underperform or produce unintended outcomes
• Making trust a measurable operational asset rather than a communications exercise
Marissa Seligman, PharmD, VP, Clinical Data Optimization, Real-World Data Solutions - Optum Life Sciences
Alyce Kuklinski, NP, RN ,VP, Client Solutions, Real World Data Solutions - Optum Life Sciences
-
2:00 PM
Presentation: Why AI Stalls at 1% in Pharma, and How We Got to 20%
Dalbir Bains - President & CEO - Galaxy Pharmaceuticals LLC
Most pharma companies get AI to about 1% of their work and stall there, in pilots that never reach production because no one can show an inspector who checked what. Dalbir Bains, CEO of Galaxy Pharmaceuticals, a 503B outsourcing facility in Albany, New York, shows how Galaxy moved AI to 20% of its work inside a cGMP operation without a single compliance shortcut, with a live demo: a deviation goes from logged to a drafted investigation and CAPA, and a person reviews and signs at every step.
- Why AI stalls at 1%: the blocker in pharma isn't the model. It's data that isn't connected and work that no one can trace.
- AI does the work, people keep the signatures: every AI output is reviewed and signed by a named owner, which is what makes it inspection-ready.
- Agents follow the SOPs: each agent runs a procedure step by step and has a human owner, so it holds the process accountable instead of bypassing it.
- Measure tools, not pilots: connect every system first, then judge progress by the tools in people's hands.
-
2:30 PM
Closing Remarks
-
2:50 PM
End of the Summit
Not Found
AI in Healthcare & Pharma Summit
AI in Healthcare & Pharma Summit
November 17-18, 2026
Register Interest